{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Menactra%C2%AE", "query": { "intervention": "Menactra®" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 41, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Menactra%C2%AE&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T00:04:22.940Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00777790", "title": "Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcemia" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "13 Years to 21 Years" }, "enrollment_count": 241, "start_date": "2004-02", "completion_date": "2005-04", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 9, "location_summary": "Atlanta, Georgia • Marietta, Georgia • Woburn, Massachusetts + 6 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Woburn", "state": "Massachusetts" }, { "city": "Albany", "state": "New York" }, { "city": "Akron", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00777790" }, { "nct_id": "NCT02199691", "title": "Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Adacel®: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed", "type": "BIOLOGICAL" }, { "name": "GARDASIL®: Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "10 Years to 17 Years" }, "enrollment_count": 1715, "start_date": "2014-07-22", "completion_date": "2015-10-02", "has_results": true, "last_update_posted_date": "2022-04-04", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 35, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Downey, California + 28 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Downey", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Miami Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02199691" }, { "nct_id": "NCT02752906", "title": "Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W 135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 810, "start_date": "2016-04-15", "completion_date": "2016-12-19", "has_results": true, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mesa, Arizona + 24 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Downey", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02752906" }, { "nct_id": "NCT02842853", "title": "Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "10 Years to 55 Years" }, "enrollment_count": 3344, "start_date": "2016-07-15", "completion_date": "2017-02-28", "has_results": true, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 89, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Mobile, Alabama + 72 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02842853" }, { "nct_id": "NCT02842866", "title": "Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningitis", "Meningococcal Meningitis", "Meningococcal Infections" ], "interventions": [ { "name": "Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Polysaccharide Vaccine, Groups A, C, Y, and W-135 Combined", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "56 Years", "maximum_age": null, "sex": "ALL", "summary": "56 Years and older" }, "enrollment_count": 907, "start_date": "2016-07-15", "completion_date": "2017-02-13", "has_results": true, "last_update_posted_date": "2022-04-05", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 35, "location_summary": "Chandler, Arizona • Anaheim, California • San Diego, California + 28 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Waterbury", "state": "Connecticut" }, { "city": "Clearwater", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02842866" }, { "nct_id": "NCT02097849", "title": "Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Relapsing Forms of Multiple Sclerosis" ], "interventions": [ { "name": "dimethyl fumarate", "type": "DRUG" }, { "name": "tetanus diphtheria toxoids vaccine", "type": "BIOLOGICAL" }, { "name": "23-valent pneumococcal polysaccharide vaccine", "type": "BIOLOGICAL" }, { "name": "meningococcal polysaccharide diphtheria conjugate vaccine (quadrivalent)", "type": "BIOLOGICAL" }, { "name": "non-pegylated interferon", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 71, "start_date": "2015-02-28", "completion_date": "2016-05-02", "has_results": true, "last_update_posted_date": "2017-06-02", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 14, "location_summary": "Gilbert, Arizona • Thornton, Colorado • Fort Lauderdale, Florida + 11 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Thornton", "state": "Colorado" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02097849" }, { "nct_id": "NCT00728260", "title": "36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Meningitis", "Meningococcal Disease" ], "interventions": [ { "name": "None administered in this study", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1421, "start_date": "2005-07", "completion_date": "2013-05", "has_results": true, "last_update_posted_date": "2015-02-12", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 1, "location_summary": "Oakland, California", "locations": [ { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00728260" }, { "nct_id": "NCT06128733", "title": "Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Meningococcal Immunisation", "Healthy Volunteers" ], "interventions": [ { "name": "Pentavalent Meningococcal ABCYW vaccine", "type": "BIOLOGICAL" }, { "name": "MenACYW conjugate vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal group B vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" }, { "name": "MenABCYW conjugate vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 1215, "start_date": "2023-10-31", "completion_date": "2025-08-27", "has_results": false, "last_update_posted_date": "2026-01-13", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 46, "location_summary": "Birmingham, Alabama • Guntersville, Alabama • Tempe, Arizona + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Guntersville", "state": "Alabama" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Harrisburg", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06128733" }, { "nct_id": "NCT01165242", "title": "Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "Meningococcal vaccine GSK 134612", "type": "BIOLOGICAL" }, { "name": "Menactra®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 1013, "start_date": "2010-08-19", "completion_date": "2011-07-29", "has_results": true, "last_update_posted_date": "2018-06-26", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 24, "location_summary": "Chandler, Arizona • Paramount, California • Sacramento, California + 19 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Paramount", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Santa Rosa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01165242" }, { "nct_id": "NCT00282295", "title": "US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acellular Pertussis", "Tetanus", "Diphtheria" ], "interventions": [ { "name": "Boostrix®", "type": "BIOLOGICAL" }, { "name": "Menactra™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "11 Years to 18 Years" }, "enrollment_count": 1344, "start_date": "2006-01-25", "completion_date": "2006-08-08", "has_results": true, "last_update_posted_date": "2018-08-17", "last_synced_at": "2026-09-03T00:04:22.940Z", "location_count": 24, "location_summary": "Chandler, Arizona • Little Rock, Arkansas • Fountain Valley, California + 18 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Golden", "state": "Colorado" }, { "city": "Marietta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00282295" } ] }